COMP <GO>
DE vs TMO // RSI-14 & 200D SMA MOMENTUM
Deere & Company (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: DE 6
— TMO 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: DE
LAST: $675.48 (+2.35%) • MKT CAP: $177.95B
rsi-technicals
59.6
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
rsi-technicals
59.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DE VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DE | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 9.30% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.9x | 30.4x | -2.50 | DE | /valuation <GO> |
| Free Cash Flow Yield | 3.43% | 2.40% | +1.03 | DE | /fcf-yield <GO> |
| Operating Margin | 13.40% | 17.40% | -4.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 11.00% | 15.10% | -4.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -11.70% | 3.90% | -15.60 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.97% | 0.24% | +0.73 | DE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.00 | 4.50 | -1.50 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 59.6 | 59.1 | +0.46 | DE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.94 | +0.01 | DE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.9x | 36.3x | -3.40 | DE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $177.95B | $262.22B | -$84.26B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DE REV | TMO REV | DE GROSS % | TMO GROSS % | DE FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.68B | $44.56B | 44.0% | 44.0% | $6.10B | $6.29B |
| FY 2024 | $51.72B | $42.88B | 44.0% | 44.0% | $7.59B | $7.27B |
| FY 2023 | $61.25B | $42.86B | 44.0% | 44.0% | $5.83B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DE // BETA 0.95
TMO // BETA 0.94